Role of E3 Ubiquitin Ligases in Lung Cancer

Overview

Journal World J Clin Oncol

Publisher Baishideng Publishing Group

Specialty Oncology

Date 2013 Aug 13

PMID 23936758

Citations 20

Authors

Barbara C Snoek

Leonie Ham de Wilt

Gerrit Jansen

Godefridus J Peters

Affiliations

Soon will be listed here.

Abstract

E3 ubiquitin ligases are a large family of proteins that catalyze the ubiquitination of many protein substrates for targeted degradation by the 26S proteasome. Therefore, E3 ubiquitin ligases play an essential role in a variety of biological processes including cell cycle regulation, proliferation and apoptosis. E3 ubiquitin ligases are often found overexpressed in human cancers, including lung cancer, and their deregulation has been shown to contribute to cancer development. However, the lack of specific inhibitors in clinical trials is a major issue in targeting E3 ubiquitin ligases with currently only one E3 ubiquitin ligase inhibitor being tested in the clinical setting. In this review, we focus on E3 ubiquitin ligases that have been found deregulated in lung cancer. Furthermore, we discuss the processes in which they are involved and evaluate them as potential anti-cancer targets. By better understanding the mechanisms by which E3 ubiquitin ligases regulate biological processes and their exact role in carcinogenesis, we can improve the development of specific E3 ubiquitin ligase inhibitors and pave the way for novel treatment strategies for cancer patients.

Citing Articles

Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.

Lin L, Wu X, Jiang Y, Deng C, Luo X, Han J PeerJ. 2022; 10:e13402.

PMID: 35646490 PMC: 9138047. DOI: 10.7717/peerj.13402.

NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling.

Chen Y, Hong H, Wang Q, Li J, Zhang W, Chen T Cancer Cell Int. 2021; 21(1):631.

PMID: 34838005 PMC: 8626996. DOI: 10.1186/s12935-021-02341-9.

The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer.

Jin J, Puranik N, Bui Q, Yadav D, Lee P Int J Mol Sci. 2021; 22(17).

PMID: 34502538 PMC: 8431782. DOI: 10.3390/ijms22179629.

Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma.

Guo M, Ding P, Zhu Z, Fan L, Zhou Y, Yang S Front Cell Dev Biol. 2021; 9:675939.

PMID: 33968945 PMC: 8097052. DOI: 10.3389/fcell.2021.675939.

TRIM11 Promotes Proliferation, Migration, Invasion and EMT of Gastric Cancer by Activating β-Catenin Signaling.

Lan Q, Tan X, He P, Li W, Tian S, Dong W Onco Targets Ther. 2021; 14:1429-1440.

PMID: 33658804 PMC: 7920621. DOI: 10.2147/OTT.S289922.

References

Carthew R, Rubin G . seven in absentia, a gene required for specification of R7 cell fate in the Drosophila eye. Cell. 1990; 63(3):561-77. DOI: 10.1016/0092-8674(90)90452-k. View

Mizuno Y, Hattori N, Mori H, Suzuki T, Tanaka K . Parkin and Parkinson's disease. Curr Opin Neurol. 2001; 14(4):477-82. DOI: 10.1097/00019052-200108000-00008. View

Garnett M, Mansfeld J, Godwin C, Matsusaka T, Wu J, Russell P . UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit. Nat Cell Biol. 2009; 11(11):1363-9. PMC: 2875106. DOI: 10.1038/ncb1983. View

Sasaki H, Moriyama S, Nakashima Y, Yukiue H, Fukai I, Fujii Y . Decreased Hrad6B expression in lung cancer. Acta Oncol. 2004; 43(6):585-9. DOI: 10.1080/02841860410014920. View

Sasaki H, Yukiue H, Kobayashi Y, Moriyama S, Nakashima Y, Kaji M . Expression of the sensitive to apoptosis gene, SAG, as a prognostic marker in nonsmall cell lung cancer. Int J Cancer. 2001; 95(6):375-7. DOI: 10.1002/1097-0215(20011120)95:6<375::aid-ijc1066>3.0.co;2-l. View

Gu Q, Bowden G, Normolle D, Sun Y . SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB. J Cell Biol. 2007; 178(6):1009-23. PMC: 2064624. DOI: 10.1083/jcb.200612067. View

Hakem A, Bohgaki M, Lemmers B, Tai E, Salmena L, Matysiak-Zablocki E . Role of Pirh2 in mediating the regulation of p53 and c-Myc. PLoS Genet. 2011; 7(11):e1002360. PMC: 3219591. DOI: 10.1371/journal.pgen.1002360. View

Hicke L . Protein regulation by monoubiquitin. Nat Rev Mol Cell Biol. 2001; 2(3):195-201. DOI: 10.1038/35056583. View

Machida Y, Machida Y, Chen Y, Gurtan A, Kupfer G, DAndrea A . UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell. 2006; 23(4):589-96. DOI: 10.1016/j.molcel.2006.06.024. View

10.

Hofmann R, Pickart C . Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair. Cell. 1999; 96(5):645-53. DOI: 10.1016/s0092-8674(00)80575-9. View

11.

Marois L, Vaillancourt M, Marois S, Proulx S, Pare G, Rollet-Labelle E . The ubiquitin ligase c-Cbl down-regulates FcgammaRIIa activation in human neutrophils. J Immunol. 2009; 182(4):2374-84. DOI: 10.4049/jimmunol.0801420. View

12.

Ciechanover A, Finley D, Varshavsky A . Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell. 1984; 37(1):57-66. DOI: 10.1016/0092-8674(84)90300-3. View

13.

Bornstein G, Bloom J, Sitry-Shevah D, Nakayama K, Pagano M, Hershko A . Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J Biol Chem. 2003; 278(28):25752-7. DOI: 10.1074/jbc.M301774200. View

14.

Zhang X, Xiao T, Cheng S, Tong T, Gao Y . Cigarette smoke suppresses the ubiquitin-dependent degradation of OLC1. Biochem Biophys Res Commun. 2011; 407(4):753-7. DOI: 10.1016/j.bbrc.2011.03.095. View

15.

Ferlay J, Parkin D, Steliarova-Foucher E . Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010; 46(4):765-81. DOI: 10.1016/j.ejca.2009.12.014. View

16.

Toby G, Gherraby W, Coleman T, Golemis E . A novel RING finger protein, human enhancer of invasion 10, alters mitotic progression through regulation of cyclin B levels. Mol Cell Biol. 2003; 23(6):2109-22. PMC: 149478. DOI: 10.1128/MCB.23.6.2109-2122.2003. View

17.

Zhang Y, Gao J, Chung K, Huang H, Dawson V, Dawson T . Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A. 2000; 97(24):13354-9. PMC: 27228. DOI: 10.1073/pnas.240347797. View

18.

Hu G, Chung Y, Glover T, Valentine V, Look A, Fearon E . Characterization of human homologs of the Drosophila seven in absentia (sina) gene. Genomics. 1997; 46(1):103-11. DOI: 10.1006/geno.1997.4997. View

19.

Kane R, Bross P, Farrell A, Pazdur R . Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist. 2003; 8(6):508-13. DOI: 10.1634/theoncologist.8-6-508. View

20.

Sarikas A, Hartmann T, Pan Z . The cullin protein family. Genome Biol. 2011; 12(4):220. PMC: 3218854. DOI: 10.1186/gb-2011-12-4-220. View